454 related articles for article (PubMed ID: 28610537)
1. Overcoming multiple myeloma drug resistance in the era of cancer 'omics'.
Guang MHZ; McCann A; Bianchi G; Zhang L; Dowling P; Bazou D; O'Gorman P; Anderson KC
Leuk Lymphoma; 2018 Mar; 59(3):542-561. PubMed ID: 28610537
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometrium.
Altmäe S; Esteban FJ; Stavreus-Evers A; Simón C; Giudice L; Lessey BA; Horcajadas JA; Macklon NS; D'Hooghe T; Campoy C; Fauser BC; Salamonsen LA; Salumets A
Hum Reprod Update; 2014; 20(1):12-28. PubMed ID: 24082038
[TBL] [Abstract][Full Text] [Related]
3. Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma.
Chanukuppa V; Taware R; Chatterjee T; Sharma S; More TH; Taunk K; Kumar S; Santra MK; Rapole S
Curr Top Med Chem; 2018; 18(30):2584-2598. PubMed ID: 30499398
[TBL] [Abstract][Full Text] [Related]
4. A role for ecophysiology in the 'omics' era.
Flexas J; Gago J
Plant J; 2018 Oct; 96(2):251-259. PubMed ID: 30091802
[TBL] [Abstract][Full Text] [Related]
5. Maternal sepsis in the era of genomic medicine.
Kouskouti C; Evangelatos N; Brand A; Kainer F
Arch Gynecol Obstet; 2018 Jan; 297(1):49-60. PubMed ID: 29103195
[TBL] [Abstract][Full Text] [Related]
6. Integrating multiple 'omics' analysis for microbial biology: application and methodologies.
Zhang W; Li F; Nie L
Microbiology (Reading); 2010 Feb; 156(Pt 2):287-301. PubMed ID: 19910409
[TBL] [Abstract][Full Text] [Related]
7. Omics in urology: An overview on concepts, current status and future perspectives.
Panunzio A; Tafuri A; Princiotta A; Gentile I; Mazzucato G; Trabacchin N; Antonelli A; Cerruto MA
Urologia; 2021 Nov; 88(4):270-279. PubMed ID: 34169788
[TBL] [Abstract][Full Text] [Related]
8. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
9. The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies.
Harding T; Baughn L; Kumar S; Van Ness B
Leukemia; 2019 Apr; 33(4):863-883. PubMed ID: 30683909
[TBL] [Abstract][Full Text] [Related]
10. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
[TBL] [Abstract][Full Text] [Related]
11. What did we learn from 'omics' studies in osteoarthritis.
Ruiz-Romero C; Rego-Perez I; Blanco FJ
Curr Opin Rheumatol; 2018 Jan; 30(1):114-120. PubMed ID: 29035928
[TBL] [Abstract][Full Text] [Related]
12. New stationary phases for enrichment and separation in the 'omics' era.
Bakry R; Rainer M; Huck CW; Bonn GK
Bioanalysis; 2009 Apr; 1(1):151-69. PubMed ID: 21083194
[TBL] [Abstract][Full Text] [Related]
13. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
14. Application of omics technologies in dermatological research and skin management.
He J; Jia Y
J Cosmet Dermatol; 2022 Feb; 21(2):451-460. PubMed ID: 33759323
[TBL] [Abstract][Full Text] [Related]
15. Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes.
Hernández-Vargas P; Muñoz M; Domínguez F
Hum Reprod Update; 2020 Feb; 26(2):264-301. PubMed ID: 32096829
[TBL] [Abstract][Full Text] [Related]
16. Multiomics technologies: role in disease biomarker discoveries and therapeutics.
Dar MA; Arafah A; Bhat KA; Khan A; Khan MS; Ali A; Ahmad SM; Rashid SM; Rehman MU
Brief Funct Genomics; 2023 Apr; 22(2):76-96. PubMed ID: 35809340
[TBL] [Abstract][Full Text] [Related]
17. Omics technologies in personalized combination therapy for cardiovascular diseases: challenges and opportunities.
Banerjee S; Prabhu Basrur N; Rai PS
Per Med; 2021 Sep; 18(6):595-611. PubMed ID: 34689602
[TBL] [Abstract][Full Text] [Related]
18. Advances in Multi-Omics Approaches for Molecular Breeding of Black Rot Resistance in
Shaw RK; Shen Y; Wang J; Sheng X; Zhao Z; Yu H; Gu H
Front Plant Sci; 2021; 12():742553. PubMed ID: 34938304
[No Abstract] [Full Text] [Related]
19. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke.
Montaner J; Ramiro L; Simats A; Tiedt S; Makris K; Jickling GC; Debette S; Sanchez JC; Bustamante A
Nat Rev Neurol; 2020 May; 16(5):247-264. PubMed ID: 32322099
[TBL] [Abstract][Full Text] [Related]
20. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
